On this page
In this issue
-
FDA & US regulatory
Letters, guidance, enforcement
-
CISA KEV & CVEs
Vulnerabilities in your SBOM
-
Standards & international
AAMI, ISO, IEC, EU MDCG
-
What to do this week
Concrete actions for security leads
Key Takeaways
- The Extended Life Support period for Red Hat Enterprise Linux (RHEL) 7 has officially concluded.
- CISA added CVE-2026-0511, a use-after-free vulnerability in the Linux kernel, to its Known Exploited Vulnerabilities catalog.
- The FDA expects documented migration plans or compensating controls for any devices still utilizing unsupported RHEL 7 environments.
- Embedded medical device platforms using affected Linux kernel versions are now under accelerated remediation timelines.
- Software Bill of Materials (SBOM) accuracy is critical for identifying whether current fleets are susceptible to the latest KEV additions.
[DIRECT ANSWER] The recent end of support for RHEL 7 and the addition of a significant Linux kernel vulnerability to the CISA KEV catalog represent major compliance and security hurdles. Manufacturers must now provide compensating controls for legacy systems or execute immediate patching cycles for embedded Linux platforms.
While the last seven days have been quiet regarding new publications, the regulatory landscape has shifted significantly over the past quarter. Manufacturers are currently navigating the transition period following the expiration of long-term support for foundational operating systems and the discovery of exploited vulnerabilities in the Linux kernel core.
This brief recaps the most critical updates from the last 90 days to ensure regulatory and security leads remain aligned with expectations from the FDA and federal security mandates.
In this brief
- RHEL 7 Extended Life Support Ends
- CISA Adds Linux Kernel Vulnerability to KEV Catalog
- Why This Matters
- What to do this week
- How Blue Goat Cyber Helps
- FAQ
- Get the next issue
Why This Matters
For medical device manufacturers, the end of platform support is not just a technical issue but a regulatory one. When an operating system enters end-of-life status, the absence of security errata makes demonstrating postmarket safety difficult. Simultaneously, when vulnerabilities like those in the Linux kernel netfilter are actively exploited in the wild, the burden of proof shifts to the manufacturer to show they are managing these risks before they impact patient safety.
RHEL 7 Extended Life Support Ends
As of June 30, 2026, Red Hat Enterprise Linux 7 has reached the end of its Extended Life Support (ELS) phase.
CISA Adds Linux Kernel Vulnerability to KEV Catalog
In late April, CISA added CVE-2026-0511 to the Known Exploited Vulnerabilities (KEV) catalog.
How Blue Goat Cyber Helps
The team at Blue Goat Cyber, led by Christian Espinosa, assists manufacturers in navigating the complex intersection of cybersecurity and regulatory compliance. We provide specialized services to help you build defensible postmarket files, manage vulnerability disclosures, and ensure your devices meet the expectations of both the FDA and healthcare providers.
FAQ
Get the next issue
Weekly updates are available at /weekly.